Vicki L. Dodson - 12 Jun 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Sr.VP Patient Srvcs
Signature
/s/ Vicki L Dodson
Issuer symbol
NHC
Transactions as of
12 Jun 2025
Net transactions value
-$110,324
Form type
4
Filing time
16 Jun 2025, 16:24:12 UTC
Previous filing
06 Mar 2025
Next filing
26 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dodson Vicki L Sr.VP Patient Srvcs 100 VINE STREET, MURFREESBORO /s/ Vicki L Dodson 12 Jun 2025 0001779472

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Shares of Common Stock held in my name Options Exercise $201,358 +3,733 +49% $53.94 11,280 12 Jun 2025 Direct F1
transaction NHC Shares of Common Stock held in my name Tax liability $262,550 -2,511 -22% $104.56 8,769 12 Jun 2025 Direct F2
transaction NHC Shares of Common Stock held in my name Options Exercise $238,827 +3,734 +43% $63.96 12,503 12 Jun 2025 Direct F3
transaction NHC Shares of Common Stock held in my name Tax liability $287,958 -2,754 -22% $104.56 9,749 12 Jun 2025 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -3,734 -100% $0.000000 0 12 Jun 2025 Common Stock 3,734 $63.96 Direct F3
transaction NHC Option to Purchase Common Stock Options Exercise $0 -3,733 -50% $0.000000 3,734 12 Jun 2025 Common Stock 7,467 $53.94 Direct F1
holding NHC Option to Purchase Common Stock 12,000 12 Jun 2025 Common Stock 12,000 $94.10 Direct
holding NHC Option to Purchase Common Stock 13,500 12 Jun 2025 Common Stock 13,500 $90.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
F3 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F4 Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form.